A new method of extracting bacterial and yeast DNA from blood products dependent on guanidinium thiocyanate acid extraction and proteinase K treatment is described. In spiked samples the sensitivity per 0.1 ml of serum and blood, respectively, was 26 and 150 colony forming units (cfu) for Escherichia coli, 80 and 120 cfu for Staphylococcus aureus and 20 and 26 cfu for Candida albicans. This compared well with existing methodologies, worked on limited clinical samples and was not pathogen specific.
The rational treatment of pyrexial infected patients with negative blood cultures would be greatly helped by the development of tests for detecting circulating microbial DNA. This would allow for the initial selection of specific therapy which would eliminate unnecessary side effects as a result of use inappropriate antibiotics and reduce costs. Recent work has seen the application of PCR with universal bacterial primers to the diagnosis of meningitis.' This work could be extended to blood provided that a sensitive method for preparing DNA was developed. An AT-3' (RWO1) and 5'-AGG AGG TGA TCC AAC CGC A-3' (G974). 4 For Candida, these were 5'-GCA TCG ATG AAG AAC GCA GC-3' (ITS3) and 5'-TCC TCC GCT TAT TGA TAT GC-3' (ITS4 gl of the amplified product was run on a 1%
agarose gel in the presence of ethidium bromide (0.5 gg/ml) for one to two hours at 55 volts and visualised by ultraviolet illumination.
IDENTIFICATION OF PRODUCTS
The sequences of specific probes were 5'-AT TGC TTG CGG CGG TAA CGT CC-3' for C albicans,5 5'-GCC GGT GGA GTA ACC TTT TAG GAG C-3' (RDR 327) for S aureus4 and 5'-GGC GCT TAC CAC TTT GTG ATT CAT G-3' (RDR 140) for E coli.'
The PCR product was denatured by heating at 95°C for 10 minutes and transferred onto a nylon membrane (Hybond-N; Amersham). It was bound by ultraviolet crosslinking with a transilluminator (Stratalinker 2400) at 254 nm for three minutes. Probes were 3-end labelled with digoxigenin (DIG)-ddUTP by the enzyme terminal transferase according to the manufacturer's directions (DIG-oligonucleotide 3'-end labelling kit; Boehringer Mannheim Biochemica). The DIG labelled probes were used to detect the membrane bound DNA in conjunction with an antibody conjugate (antidigoxigenin alkaline phosphatase conjugate). A subsequent enzyme catalysed colour reaction with 5-bromo-4-chloro-3-indolylphosphate (Xphosphate) and nitro blue tetrazolium salt (NBT) produced an insoluble blue precipitate, which visualised the hybrid molecules.
Results

SENSITIVITY OF DNA EXTRACTION METHOD
The sensitivity for E coli detection for whole blood was 150 and for serum 26 colony forming units (cfu) per 0.1 ml. A titration of E coli from 2.6 x 109 cfu/0.1 ml to 26 cfu/0.1 ml is illustrated in fig 1. The equivalent figures for S aureus were 120 cfu/0. 1 ml (whole blood) and 80 cfu/0. 1 ml (serum) and for C albicans 26 cfu/0. 1 ml (whole blood) and 20 cfu/0.1 ml (serum). The endpoint was visualised on an ethidium bromide stained gel and the identity confirmed by probing with DIG labelled oligonucleotides.
The technique was positive for the serum samples from individual patients with a septicaemia caused by C albicans, S aureus or E coli. The candidal product was absent from a subsequent sample taken from the same patient 10 days later, which correlated with a clinical response to amphotericin B and negative blood cultures.
Discussion
This paper has reported a universal method of purifying microbial DNA. The sensitivity for E coli with serum was 26 cfu/0. 1 ml. This can be compared favourably with the method of Hoon Song et al6 for Salmonella typhi, in which mononuclear cells were obtained from whole blood after density centrifugation with FicollHypaque, incubated with lysozyme and proteinase K and the DNA was extracted with phenol-chloroform-isoamylalcohol. The sensitivity when purified S typhi DNA was mixed with mononuclear cell DNA was 4 ng, equivalent to 106 organisms.
The limit of detection for S aureus with serum was 80 cfu/0. 1 ml. This is as good as the results reported with other Gram positive bacteria. Ubukata et al'2 performed PCR for the staphylococcal methicillin gene. DNA extraction was based on lysostaphin lysis which is specific to staphylococci and achieved a sensitivity of 5 x 102 cfu/tube for S aureus after probing. In the case of Streptococcus pneumoniae, whole blood digested by proteinase K followed by phenol-chloroform-isoamylalcohol extraction was positive at 4 x 102 cfu/0. 1 ml. 7 A lysis method reported subsequently achieved a sensitivity of only 80% on clinical material despite being positive with as little as 4 cfu/ml in spiked specimens.19
The technique reported for candidal DNA extraction achieved a sensitivity comparable with other studies. Burgener-Kairuz et al,"
applying PCR for detecting the cytochrome P-450 lanosterol-a-demethylase gene of C albicans after zymolase treatment, achieved a sensitivity of 10 to 20 cells/0.1 ml of seeded blood but only 71% in 80 clinical specimens. This was improved by the development of a nested PCR where five of seven patients with candidiasis were positive.'4 Lyticase extraction failed unless inhibitors were removed by glass adhesion20 or the sensitivity was low at 150 to 200 cells/0. 1 ml. 2 If non-yeast DNA was removed by pretreatment this increased to 10 to 15 cells/0. 1 ml.22 A combination of zymolase extraction, lysis, proteinase K treatment, and phenol chloroform extraction was positive for two C albicans cells/0.2 ml blood, but this was only after probing.5
Prior purification with candidal specific antibody resulted in an assay capable of detecting three cells of C albicanslO. 1 ml." A mixture of mechanical disruption with glass beads, protein digestion and DNA extraction produced a test with a detection rate of only 79% in cases of systemic candidiasis." In summary, this paper reports a universal method for extracting bacterial or fungal DNA from blood products. The sensitivity, as judged by seeded samples, was similar or better than that reported previously. This is likely to be increased when the technique is combined with probing. It was also evaluated successfully in a limited number of clinical samples. Thus, it could form the basis of a stategy for improving diagnosis. Microbial DNA extracted by this method would be amplified with universal primers. The pattern could be used to demonstrate whether the infection was Gram positive, Gram negative or yeast. This would lead to a more rational use of antibiotics. The precise microbe could then be identified by probing the product with a battery of specific probes. 
